TAG ARCHIVE
POSTS TAGGED AS CRISPR Therapeutics
Gene Editing Shows Long Term Efficacy forBeta Thalassemia and Sickle Cell Disease
August 23, 2022 | Terry Sharrer | Posted in Newsletter
Sickle Cell Anemia
“In a late-breaking abstract presented at the European Hematology Association (EHA) Congress, a group of researchers that includes [MORE]
